Consumers are on board, with an estimated 26% of U.S. adults planning to take a weight loss drug in 2025, according to eMarketer. Obesity drugs have also started showing up in employer health care packages, although cost constraints are limiting plan availability.
7 Best Weight Loss Drug Stocks to Buy in 2025
view original post